Search

Your search keyword '"Springfeld, Christoph"' showing total 527 results

Search Constraints

Start Over You searched for: Author "Springfeld, Christoph" Remove constraint Author: "Springfeld, Christoph"
527 results on '"Springfeld, Christoph"'

Search Results

3. Metavert synergises with standard cytotoxics in human PDAC organoids and is associated with transcriptomic signatures of therapeutic response

4. Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC

6. Carbon ion radiotherapy of hepatocellular carcinoma provides excellent local control: The prospective phase I PROMETHEUS trial

9. Deep Learning–Enabled Diagnosis of Liver Adenocarcinoma

14. Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy

15. Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial

18. Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma

22. Metastatic adult pancreatoblastoma: Multimodal treatment and molecular characterization of a very rare disease

23. The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring NRG1 gene fusions

24. Repotrectinib in ROS1 Fusion–Positive Non–Small-Cell Lung Cancer

25. Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinoma

26. Actual Five-year Survival After Upfront Resection for Pancreatic Ductal Adenocarcinoma: Who Beats the Odds?

27. Author Correction: Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy

28. HER2 gene (ERBB2) amplification is a low-frequency driver with potential predictive value in gallbladder carcinoma

32. Community-driven development of a modified progression-free survival ratio for precision oncology

33. Promising Outcomes of Modified ALPPS for Staged Hepatectomy in Cholangiocarcinoma

34. Protocol of the IntenSify‐Trial: An open‐label phase I trial of the CYP3A inhibitor cobicistat and the cytostatics gemcitabine and nab‐paclitaxel in patients with advanced stage or metastatic pancreatic ductal adenocarcinoma to evaluate the combination's pharmacokinetics, safety, and efficacy

35. Etiology-independent activation of the LTβ-LTβR-RELB axis drives aggressiveness and predicts poor prognosis in HCC

36. Location of tissue associated macrophages M2 in pancreatic cancer

37. Safety of multimodality treatment with a combination of intra- operative chemotherapy and surgical resection in locally confined or borderline resectable pancreatic cancer: The combiCaRe study

38. Personalized treatment in localized pancreatic cancer

39. Association of perioperative use of statins, metformin, and aspirin with recurrence after curative liver resection in patients with hepatocellular carcinoma: A propensity score matching analysis

43. CATCH: A Prospective Precision Oncology Trial in Metastatic Breast Cancer

45. Sequential systemic treatment in patients with hepatocellular carcinoma: real-world data in the era of immune checkpoint inhibition

48. HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis

49. Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma – correlation with clinicopathological data and comparison of antibodies

50. Supplementary Patient Data from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer

Catalog

Books, media, physical & digital resources